US23257B1070 - Common Stock

**CYN** gets a fundamental rating of **3** out of 10. The analysis compared the fundamentals against 283 industry peers in the **Software** industry. While **CYN** has a great health rating, there are worries on its profitability. **CYN** does not seem to be growing, but still is valued expensively.

In the past year **CYN** has reported negative net income.

In the past year **CYN** has reported a negative cash flow from operations.

The **Return On Assets** of **CYN** (**-146.47%**) is worse than **92.88%** of its industry peers.

Looking at the **Return On Equity**, with a value of **-163.49%**, **CYN** is doing worse than **79.72%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -146.47% | ||

ROE | -163.49% | ||

ROIC | N/A |

ROA(3y)-78.3%

ROA(5y)N/A

ROE(3y)-87.92%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

Looking at the **Gross Margin**, with a value of **4.76%**, **CYN** is doing worse than **88.61%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 4.76% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

Based on the Altman-Z score of **-13.93**, we must say that **CYN** is in the distress zone and has some risk of bankruptcy.

The **Altman-Z score** of **CYN** (**-13.93**) is worse than **92.53%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | N/A | ||

Altman-Z | -13.93 |

ROIC/WACCN/A

WACC10.55%

The **Current ratio** of **CYN** (**8.23**) is better than **94.66%** of its industry peers.

A Quick Ratio of **8.23** indicates that **CYN** has no problem at all paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 8.23 | ||

Quick Ratio | 8.23 |

The earnings per share for **CYN** have decreased strongly by **-48.78%** in the last year.

EPS 1Y (TTM)-48.78%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-26.67%

Revenue 1Y (TTM)N/A

Revenue growth 3Y29.4%

Revenue growth 5YN/A

Revenue growth Q2QN/A

Based on estimates for the next years, **CYN** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **21.67%** on average per year.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-18.39%

EPS Next 2Y7.8%

EPS Next 3Y21.67%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

The **Price/Earnings Ratio** is negative for **CYN**. In the last year negative earnings were reported.

Also next year **CYN** is expected to report negative earnings again, which makes the also the **Forward Price/Earnings** Ratio negative.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

A more expensive valuation may be justified as **CYN**'s earnings are expected to grow with **21.67%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y7.8%

EPS Next 3Y21.67%

No dividends for **CYN**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**CYNGN INC**

NASDAQ:CYN (12/11/2023, 4:10:44 PM)

After market: 0.169 0 (-0.65%)**0.1701**

**-0.04 (-19.76%) **

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap7.11M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -146.47% | ||

ROE | -163.49% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 4.76% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.11

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 8.23 | ||

Quick Ratio | 8.23 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-48.78%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-18.39%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)N/A

Revenue growth 3Y29.4%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y